Beyond Medical Therapy-An Update on Heart Failure Devices

Area of Science:

• Cardiology
• Biomedical Engineering
• Translational Medicine

Background:

• Heart failure (HF) presents significant morbidity, mortality, and reduced quality of life (QoL).
• Despite Guideline-Directed Medical Therapy (GDMT) and recent clinical trial advancements, mortality rates remain high and hospitalizations are increasing.
• A substantial residual risk persists in HF patients, necessitating novel therapeutic strategies.

Purpose of the Study:

• To provide an updated overview of innovative devices for heart failure (HF) management.
• To review both currently approved and investigational devices targeting valvular, structural, and autonomic abnormalities in HF.
• To highlight the translational progress in device development for addressing unmet needs in HF treatment.

Main Methods:

• Systematic literature review of recent large-scale randomized clinical trials (RCTs).
• Analysis of approved and emerging device technologies for HF.
• Focus on devices addressing valvular, structural, and autonomic dysfunction.

Main Results:

• Recent therapeutic advancements have expanded treatment options but have not halted increasing mortality and hospitalizations.
• Guideline-Directed Medical Therapy (GDMT) alone leaves a significant residual risk in heart failure patients.
• Novel devices targeting specific HF pathologies are crucial and undergoing active development.

Conclusions:

• Innovative device-based therapies are essential to address the persistent challenges in heart failure (HF) management.
• A translational boost in device development offers promising new avenues for treating HF.
• This review consolidates current knowledge on approved and investigational devices, guiding future clinical practice and research.